GenixPharmaceucticals Corporation (GENX) - Total Liabilities

Latest as of April 2026: CA$1.58 Million CAD ≈ $1.14 Million USD

Based on the latest financial reports, GenixPharmaceucticals Corporation (GENX) has total liabilities worth CA$1.58 Million CAD (≈ $1.14 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore GenixPharmaceucticals Corporation annual equity growth to track the company's year-over-year net asset growth rate.

GenixPharmaceucticals Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how GenixPharmaceucticals Corporation's total liabilities have evolved over time, based on quarterly financial data. See GENX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

GenixPharmaceucticals Corporation Competitors by Total Liabilities

The table below lists competitors of GenixPharmaceucticals Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Agronomics Ltd LSE:ANIC	UK	GBX147.60K
Procook Group PLC LSE:PROC	UK	GBX49.68 Million
IMAGE POWER S.A. ZY -10 F:7UQ	Germany	€280.97K
Panthera Resources PLC LSE:PAT	UK	GBX3.06 Million
Calnex Solutions Plc LSE:CLX	UK	GBX9.34 Million
Real Estate Investors PLC LSE:RLE	UK	GBX38.64 Million
Crystal Amber Fund Limited LSE:CRS	UK	GBX354.05K
Made Tech Group PLC LSE:MTEC	UK	GBX4.89 Million

Liability Composition Analysis (2015–2025)

This chart breaks down GenixPharmaceucticals Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GenixPharmaceucticals Corporation (GENX) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	47.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenixPharmaceucticals Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenixPharmaceucticals Corporation (2015–2025)

The table below shows the annual total liabilities of GenixPharmaceucticals Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-10-31	CA$1.47 Million ≈ $1.06 Million	+19.66%
2024-10-31	CA$1.23 Million ≈ $888.86K	-9.71%
2023-10-31	CA$1.36 Million ≈ $984.40K	+29.17%
2022-10-31	CA$1.05 Million ≈ $762.10K	+39.50%
2021-10-31	CA$755.19K ≈ $546.29K	+54.16%
2020-10-31	CA$489.88K ≈ $354.37K	+494.44%
2019-10-31	CA$82.41K ≈ $59.61K	-24.50%
2018-10-31	CA$109.15K ≈ $78.96K	-59.99%
2017-10-31	CA$272.80K ≈ $197.34K	+300.95%
2016-10-31	CA$68.04K ≈ $49.22K	-38.58%
2015-10-31	CA$110.78K ≈ $80.13K	--

About GenixPharmaceucticals Corporation

V:GENX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$664.33K

CA$918.36K CAD

Market Cap Rank

#30800 Global

#1626 in Canada

Share Price

CA$0.02

Change (1 day)

-25.00%

52-Week Range

CA$0.02 - CA$0.04

All Time High

CA$0.29